Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Measurement Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Construction and validation of an instrument for assessing the functionality of individuals with schistosomiasis

Oliveira ACD, Lima SVMA, Lopes-Sousa ÁF, et al. FapUNIFESP (SciELO). Revista Brasileira de Enfermagem. 2022;
Download PDF
Publication

Drug shops for stronger health systems: learning from initiatives in six LMICs

Lamba G, Shroff ZC, Babar Z, et al. Springer Science and Business Media LLC. Journal of Pharmaceutical Policy and Practice. 2021;
Download PDF
Publication

Verbalising importance of supply chain management in access to health services

Ghaffar A, Rashidian A, Khan W, et al. Springer Science and Business Media LLC. Journal of Pharmaceutical Policy and Practice. 2021;
Download PDF
Publication

Access to antivenoms in the developing world: A multidisciplinary analysis.

Potet J, Beran D, Ray N, et al. Toxicon: X. 2021;
Download PDF
Publication

Model-based geostatistics enables more precise estimates of neglected tropical-disease prevalence in elimination settings: mapping trachoma prevalence in Ethiopia

Amoah B, Fronterrè C, Johnson O, et al. Oxford University Press (OUP). International Journal of Epidemiology. 2021;
Download PDF
Publication

India's performance in controlling Visceral Leishmaniasis as compared to Brazil over past three decades: findings from global burden of disease study.

Dhamnetiya D, Jha R, Shalini S, et al. Journal of parasitic diseases : official organ of the Indian Society for Parasitology. 2021; 45 (4) : 877-886.
Download PDF
Publication

Strategies for effective health care for Africa in the Fourth Industrial Revolution

Signé L. Africa Growth Initiative by Brookings. 2021;
Download PDF
Publication

Parasitology and One Health—Perspectives on Africa and Beyond

Lorusso V. MDPI AG. Pathogens. 2021; 10 (11) : 1437.
Download PDF
Publication

Effects of a social norm-based handwashing intervention including handwashing stations, and a handwashing station-only intervention on handwashing with soap in urban Côte d'Ivoire: a cluster randomised controlled trial

Amon-Tanoh MA, McCambridge J, Blon PK, et al. Elsevier BV. The Lancet Global Health. 2021; 9 (12) : e1707-e1718.
Download PDF
Publication

Towards the elimination of visceral leishmaniasis as a public health problem in east Africa: reflections on an enhanced control strategy and a call for action

Alvar J, den Boer M, Dagne DA. Elsevier BV. The Lancet Global Health. 2021; 9 (12) : e1763-e1769.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 308
  • Next page ››
Subscribe to Full text online

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2026 InfoNTD